ARCHIVES

FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin

This article is from The Cancer Letter archive.

Vol. 11 No. 14 | April 5, 1985

Download PDF Visit The Full Archive

Related Articles

Peer Review changes Urged By NIH Team Include Appeals

April 8, 1977

In Congress; GAO Says Some Yew Bark Lost In ’91, But Problems Are Being Corrected

September 11, 1992

Extent Of Risk Reduction From Ovary Removal Varies According To BRCA Mutation

February 29, 2008

In Brief: George Vande Woude Of NCI Named PI for Litton Bionetics Basic Research Contract At Frederick

September 23, 1983

More DCT Concepts Approved By Advisors

July 10, 1992

Latest U.S. cancer statistics cover 84% of population.

December 5, 2003